These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36853190)

  • 1. 7-
    Nguyen W; Dans MG; Currie I; Awalt JK; Bailey BL; Lumb C; Ngo A; Favuzza P; Palandri J; Ramesh S; Penington J; Jarman KE; Mukherjee P; Chakraborty A; Maier AG; van Dooren GG; Papenfuss T; Wittlin S; Churchyard A; Baum J; Winzeler EA; Baud D; Brand S; Jackson PF; Cowman AF; Sleebs BE
    ACS Infect Dis; 2023 Mar; 9(3):668-691. PubMed ID: 36853190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
    Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
    Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
    Stickles AM; Ting LM; Morrisey JM; Li Y; Mather MW; Meermeier E; Pershing AM; Forquer IP; Miley GP; Pou S; Winter RW; Hinrichs DJ; Kelly JX; Kim K; Vaidya AB; Riscoe MK; Nilsen A
    Am J Trop Med Hyg; 2015 Jun; 92(6):1195-201. PubMed ID: 25918204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4.
    Ashton TD; Dans MG; Favuzza P; Ngo A; Lehane AM; Zhang X; Qiu D; Chandra Maity B; De N; Schindler KA; Yeo T; Park H; Uhlemann AC; Churchyard A; Baum J; Fidock DA; Jarman KE; Lowes KN; Baud D; Brand S; Jackson PF; Cowman AF; Sleebs BE
    J Med Chem; 2023 Mar; 66(5):3540-3565. PubMed ID: 36812492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b.
    Awalt JK; Su W; Nguyen W; Loi K; Jarman KE; Penington JS; Ramesh S; Fairhurst KJ; Yeo T; Park H; Uhlemann AC; Chandra Maity B; De N; Mukherjee P; Chakraborty A; Churchyard A; Famodimu MT; Delves MJ; Baum J; Mittal N; Winzeler EA; Papenfuss AT; Chowdury M; de Koning-Ward TF; Maier AG; van Dooren GG; Baud D; Brand S; Fidock DA; Jackson PF; Cowman AF; Dans MG; Sleebs BE
    Eur J Med Chem; 2024 Dec; 280():116921. PubMed ID: 39388903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of
    Lane KD; Mu J; Lu J; Windle ST; Liu A; Sun PD; Wellems TE
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6285-6290. PubMed ID: 29844160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenine Modification at C7 as a Viable Strategy to Potentiate the Antimalarial Activity of Quinolones.
    Kurian J; Kumari V; Chaluvalappil SV; Anas M; Manhas A; Kalluruttimmal R; Kumar N; Manheri MK
    ChemMedChem; 2022 Jan; 17(2):e202100472. PubMed ID: 34717044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Ubiquinol-Reduction (Q
    Amporndanai K; Pinthong N; O'Neill PM; Hong WD; Amewu RK; Pidathala C; Berry NG; Leung SC; Ward SA; Biagini GA; Hasnain SS; Antonyuk SV
    Biology (Basel); 2022 Jul; 11(8):. PubMed ID: 35892964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome
    Blake LD; Johnson ME; Siegel SV; McQueen A; Iyamu ID; Shaikh AK; Shultis MW; Manetsch R; Kyle DE
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolone-3-diarylethers: a new class of antimalarial drug.
    Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
    Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
    Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
    Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
    Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
    J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity.
    Ashton TD; Ngo A; Favuzza P; Bullen HE; Gancheva MR; Romeo O; Parkyn Schneider M; Nguyen N; Steel RWJ; Duffy S; Lowes KN; Sabroux HJ; Avery VM; Boddey JA; Wilson DW; Cowman AF; Gilson PR; Sleebs BE
    Bioorg Chem; 2021 Dec; 117():105359. PubMed ID: 34689083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Dual-Stage Malaria Inhibitors with New Targets.
    Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors.
    Lukens AK; Heidebrecht RW; Mulrooney C; Beaudoin JA; Comer E; Duvall JR; Fitzgerald ME; Masi D; Galinsky K; Scherer CA; Palmer M; Munoz B; Foley M; Schreiber SL; Wiegand RC; Wirth DF
    J Infect Dis; 2015 Apr; 211(7):1097-103. PubMed ID: 25336726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.